The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading
Complex combination of factors are driving the market of specialty excipients for OSDF globally
On a global scale, the oral solid dosage form (OSDF) excipients market is growing sustainably, historically exhibiting a robust increase. This market is valued at nearly $2.3 billion in the United States, Europe, India, and China, according to recently published Specialty Excipients for Oral Solid Dosage Form Pharmaceuticals Global Series: Business Analysis and Opportunities by worldwide consulting and research firm Kline & Company.Continue reading
Excipients are the unsung heroes of the oral solid-dosage-form (OSDF) pharmaceutical industry, seemingly content to remain out of the limelight and let the active ingredients take center stage. Now, a new breed of specially formulated blends could be just what the doctor ordered to help drug makers optimize production and potentially reduce the cost of producing life-saving medications.
Most consumers are completely unaware of the critical role excipients play in delivering the beneficial medicines millions rely on to fight diseases and stay healthy. Yet it is the fillers, binders, disintegrants, lubricants, and coatings that ensure the accurate, timed delivery of drugs required to safely maintain optimum active ingredient levels in our system and give the OSDF drugs we take every day their palpable size, texture, and flavor.Continue reading